Literature DB >> 23868013

The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.

Rong Li1, Arthur C K Chung, Yuan Dong, Weiqin Yang, Xiang Zhong, Hui Y Lan.   

Abstract

The TGF-β/Smad3 pathway plays a major role in tissue fibrosis, but the precise mechanisms are not fully understood. Here we identified microRNA miR-433 as an important component of TGF-β/Smad3-driven renal fibrosis. The miR-433 was upregulated following unilateral ureteral obstruction, a model of aggressive renal fibrosis. In vitro, overexpression of miR-433 enhanced TGF-β1-induced fibrosis, whereas knockdown of miR-433 suppressed this response. Furthermore, Smad3, but not Smad2, bound to the miR-433 promoter to induce its expression. Delivery of an miR-433 knockdown plasmid to the kidney by ultrasound microbubble-mediated gene transfer suppressed the induction and progression of fibrosis in the obstruction model. The antizyme inhibitor Azin1, an important regulator of polyamine synthesis, was identified as a target of miR-433. Overexpression of miR-433 suppressed Azin1 expression, while, in turn, Azin1 overexpression suppressed TGF-β signaling and the fibrotic response. Thus, miR-433 is an important component of TGF-β/Smad3-induced renal fibrosis through the induction of a positive feedback loop to amplify TGF-β/Smad3 signaling, and may be a potential therapeutic target in tissue fibrosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23868013     DOI: 10.1038/ki.2013.272

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  57 in total

Review 1.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 2.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

Review 3.  Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?

Authors:  Yu Liu; Zheng Dong; Hong Liu; Jiefu Zhu; Fuyou Liu; Guochun Chen
Journal:  Perit Dial Int       Date:  2015 Jan-Feb       Impact factor: 1.756

4.  Cardiac fibrosis and miR-433.

Authors:  Jae Gyun Oh; Roger J Hajjar; Woo Jin Park
Journal:  Ann Transl Med       Date:  2016-12

5.  Therapeutic potential of targeting microRNAs to regulate cardiac fibrosis: miR-433 a new fibrotic player.

Authors:  Jenny Y Y Ooi; Bianca C Bernardo; Julie R McMullen
Journal:  Ann Transl Med       Date:  2016-12

Review 6.  Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

Authors:  Wenshan Lv; Fan Fan; Yangang Wang; Ezekiel Gonzalez-Fernandez; Chen Wang; Lili Yang; George W Booz; Richard J Roman
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

7.  Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation.

Authors:  Qin Zhou; Xiao R Huang; Jianwen Yu; Xueqing Yu; Hui Y Lan
Journal:  Mol Ther       Date:  2015-03-06       Impact factor: 11.454

8.  Emerging role of miRNAs in renal fibrosis.

Authors:  Youling Fan; Hongtao Chen; Zhenxing Huang; Hong Zheng; Jun Zhou
Journal:  RNA Biol       Date:  2019-09-24       Impact factor: 4.652

Review 9.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

10.  Differential Expression of microRNAs in Urinary Extracellular Vesicles Obtained From Hypertensive Patients.

Authors:  Soon Hyo Kwon; Hui Tang; Ahmed Saad; John R Woollard; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Am J Kidney Dis       Date:  2016-03-16       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.